Join n-Lorem Foundation's 2024 Nano-Rare Patient Colloquium. This year’s colloquium will bring together patients, physicians, and supporters to create a cohesive, empathetic, and knowledgeable nano-rare community. This event is open to all—register now!

A new study describes the use of artificial intelligence (AI) in designing a new generation of capsids, the structures that envelop genetic material of adeno-associated viruses (AAV), to improve gene therapies for muscle diseases.

Join millions who have switched to Grok.

BioMolecular Horizons is in Melbourne this coming week26th IUBMB.17th FAOBMB.22nd ComBio.Swing by Cytiva's booth to explore breakthrough solutions and chat with our specialists to shape the future of research together.

Great commentary on the topic of in vivo CAR T therapy>.Drug developers want to reprogram immune cells directly in the body, opening up new gene therapy frontiers in cancer and autoimmunity.

Cytiva is aware that tackling scope 3 emissions can be tough. Suppliers and biopharma companies need to collaborate more closely to make strides in sustainability. Check out our review:

RT @nzkatj: Oh wow, this is some great news. Need to read the details!.

Enter for the opportunity to have your cell image on the cover of @cytotherapy .Thanks @ISCTglobal.

RT @KennethWWitwer: The Guidelines for minimal information on cellular senescence experimentation #MICSE are now available @CellCellPress:….

RT @ISCTglobal: The ISCT Early Stage Professionals Committee is looking for dedicated and enthusiastic new members to support current and u….

RT @AliciaD_nz: Loved the ISCT ANZ poster session! Great opportunity for discussion, networking, and talking about research. So impressed….

RT @EmilyBlyth5: #ISCTANZ2024 even more spectacular today as the main meeting gets underway. In the joint @ISCTglobal AND @theASSCR joint s….

See you next week in Queenstown NZ for #ISCTANZ2024

We've been busy eliminating polystyrene in packaging. Our new packaging has liners made with renewable paper and corn starch as their primary ingredients.

Did you miss the future of oligo synthesis? Don't worry, you can now access it on-demand webinar. Watch now and learn how a unicorn's magic powers can bring you up to speed as quickly as possible:

Thinking about bringing your oligo process in-house? It's a brave decision. Find out if it is for you. Explore what it entails and the benefits of owning your process in our on-demand webinar.

Calling all ÄKTA oligosynt users! Boost your yields in oligo synthesis in less than 30 minutes with our on-demand webinar. :

RT @xinoxan: 📢 The application #deadline has been extended to 2 July 2024 – apply now!.🏃‍♂️Last chance to join this year’s edition. 🔗 https….

RT @ISCTglobal: Participate in our survey to shape future technologist training programs in the field of Cell and Gene Therapy (CGT) and Ad….

There is still time to submit an abstract for @Neo_CellTherapy 2024.

RT @Atul_Monash: The final program of the 2024 @Neo_CellTherapy Symposium #NCT2024 is out. See below 👇🏽. Thank you to all the stellar speak….